335 related articles for article (PubMed ID: 17579279)
1. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
[TBL] [Abstract][Full Text] [Related]
2. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Gerdes S; Kurrat W; Mrowietz U
Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis.
Raap U; Werfel T; Goltz C; Deneka N; Langer K; Bruder M; Kapp A; Schmid-Ott G; Wedi B
Allergy; 2006 Dec; 61(12):1416-8. PubMed ID: 17073871
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
5. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
6. Serum eosinophil cationic protein in children with atopic dermatitis.
Murat-Susić S; Lipozencić J; Zizić V; Husar K; Marinović B
Int J Dermatol; 2006 Oct; 45(10):1156-60. PubMed ID: 17040428
[TBL] [Abstract][Full Text] [Related]
7. Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis.
Namura K; Hasegawa G; Egawa M; Matsumoto T; Kobayashi R; Yano T; Katoh N; Kishimoto S; Ohta M; Obayashi H; Ose H; Fukui M; Nakamura N; Yoshikawa T
Clin Immunol; 2007 Feb; 122(2):181-6. PubMed ID: 17161975
[TBL] [Abstract][Full Text] [Related]
8. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity.
Czech W; Schöpf E; Kapp A
Br J Dermatol; 1996 Jan; 134(1):17-21. PubMed ID: 8745880
[TBL] [Abstract][Full Text] [Related]
9. Neuro-mediators as predictors of paediatric atopic dermatitis.
Wang IJ; Hsieh WS; Guo YL; Jee SH; Hsieh CJ; Hwang YH; Chen PC
Clin Exp Allergy; 2008 Aug; 38(8):1302-8. PubMed ID: 18510693
[TBL] [Abstract][Full Text] [Related]
10. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
11. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
12. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables.
Park JH; Choi YL; Namkung JH; Kim WS; Lee JH; Park HJ; Lee ES; Yang JM
Br J Dermatol; 2006 Oct; 155(4):778-83. PubMed ID: 16965428
[TBL] [Abstract][Full Text] [Related]
14. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Allergol Int; 2008 Dec; 57(4):391-6. PubMed ID: 18797178
[TBL] [Abstract][Full Text] [Related]
15. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis.
Lee CH; Chuang HY; Shih CC; Jong SB; Chang CH; Yu HS
Br J Dermatol; 2006 Jun; 154(6):1100-7. PubMed ID: 16704640
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
Hon KL; Lam MC; Wong KY; Leung TF; Ng PC
Br J Dermatol; 2007 Nov; 157(5):922-5. PubMed ID: 17725670
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects.
Tomi NS; Kränke B; Aberer E
J Am Acad Dermatol; 2005 Jul; 53(1):67-72. PubMed ID: 15965423
[TBL] [Abstract][Full Text] [Related]
20. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis.
Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z
Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
